Riskpilot← Back to searchSign inGet full accessMediDerma Oy
OYDissolvedY-tunnus 2466792-6Kivirinteenkatu 13Medical specialists activities · NACE 8622Est. 2012— employees
Revenue 2025
EUR 303K
-99% vs 2024
EBITDA margin
42.8%
+1650% vs 2024
Equity ratio
96.2%
Financial strength
Net profit 2025
EUR 102K
+2713% vs 2024
| Revenue | EUR 303K | -99% |
| EBITDA | EUR 130K | +1650% |
| Net profit | EUR 102K | +2713% |
| Total assets | EUR 438K | +24% |
| Equity | EUR 422K | +21% |
| Employees | — | — |
Legal name
MediDerma Oy
Y-tunnus number
2466792-6
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
7. maaliskuuta 2012
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-05-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on tuottaa terveydenhoitopalveluja mukaan lukien lääkäripalvelut. Yhtiön toimialaan kuuluu ostaa, myydä, vuokrata asunto-osakkeita ja kiinteistöjä. Se voi harjoittaa arvopaperikauppaa.
Address
Kivirinteenkatu 13
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 255 | 273 | 251 | 30 097 | 303 |
| Staff expenses | −68 | −65 | −62 | −6 227 | −63 |
| EBITDA | 99 | 73 | 71 | 7 | 130 |
| Depreciation & amort. | −6 | −5 | −4 | −274 | −2 |
| EBIT | 92 | 68 | 67 | 5 | 128 |
| Net financials | −0 | −0 | −0 | −0 | −0 |
| Profit before tax | 92 | 68 | 67 | 5 | 128 |
| Tax | 18 | 14 | 14 | 1 | 26 |
| Net profit | 74 | 54 | 53 | 4 | 102 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 320 | 350 | 377 | 353 | 438 |
| Equity | 310 | 344 | 372 | 349 | 422 |
| Long-term debt | — | — | 0 | 0 | 0 |
| Short-term debt | 10 | 6 | 4 | 487 | 17 |
| Total debt | 10 | 6 | 4 | 5 | 17 |
EBITDA margin
42.8%
This company
15.8%
Market median
+171% vs market
20212025
Equity ratio
96.2%
This company
38.2%
Market median
+152% vs market
20212025
Return on equity
24.2%
This company
18.4%
Market median
+32% vs market
20212025
Net profit margin
33.6%
This company
8.1%
Market median
+315% vs market
20212025
Asset turnover
0.69×
This company
1.12×
Market median
-38% vs market
20212025
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2024-06-01 – 2025-05-31
- Annual report 2024Filed via PRH / YTJ · Period 2023-06-01 – 2024-05-31
- Annual report 2023Filed via PRH / YTJ · Period 2022-06-01 – 2023-05-31
- Annual report 2022Filed via PRH / YTJ · Period 2021-06-01 – 2022-05-31
- Annual report 2021Filed via PRH / YTJ · Period 2020-06-01 – 2021-05-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
SJ Deputy Member | Deputy Member | 2022 |
JM Deputy Member | Deputy Member | 2012 |
MS Chief Executive Officer | Chief Executive Officer | 2012 |
| Former (1) | ||
| Audit | 2012 – 2025 | |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MediDerma Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Santtu Johannes Jonninen | Deputy Member | 0 companies |
| Jyri Markus Jonninen | Deputy Member | 0 companies |
| Minna Satu Kaarina Kostiainen | Chief Executive Officer | 0 companies |
| Riitta Tellervo Kallio-Saukkonen | Audit | 0 companies |